A Rare Side Effect of Entecavir: Hepatomegaly and Steatosis

Journal Title: Viral Hepatitis Journal - Year 2017, Vol 23, Issue 3

Abstract

Hepatomegaly and steatosis are rare but potentially fatal side-effects of nucleoside analogues. Here, we present the case of development of hepatomegaly and steatosis in a 53-year-old male who had been treated with entecavir for five years. There were no symptoms of lactic acidosis. At three months after changing entecavir to tenofovir, the liver size returned to normal and maintained within the normal range during the 3-year follow-up. Therefore, it can be presumed that the hepatomegaly and steatosis were due to entecavir therapy. There are very few reports of hepatomegaly and steatosis caused by nucleoside analogues and the majority of the reported cases were associated with lactic acidosis. To the best of our knowledge, there are no previously reported cases of hepatomegaly and steatosis due to entecavir therapy without evidence of lactic acidosis. The aim of this clinical report was to point out a rare side-effect of entecavir and to share our treatment approach.

Authors and Affiliations

Tayibe BAL, Yusuf ÖNLEN, Selma İLKAY ŞAHİN

Keywords

Related Articles

A Comparison of Needle Types and Biopsy Techniques Used in Liver Biopsies of Chronic Hepatitis B Patients

Objectives: To investigate the effect of the biopsy technique used in percutaneous liver biopsies applied with semi-automatic 16 gauge (G) and 18G Tru-cut and Menghini aspiration needles in patients with chronic hepatiti...

Direct-acting Antiviral Therapy for Mixed Genotype Chronic Hepatitis C Infection

Objectives: Literature data concerning the outcomes of direct acting antiviral (DAA) therapy in mixed genotype hepatitis C virus (HCV) infections are very limited, and the incidence of mixed HCV infection in Turkey is un...

Frequency of Hepatitis B Virus, Hepatitis C Virus and HIV Infections in Cannabis and Opioid Addicts

Objective: There are very few data about the epidemiology of hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV infections in drug addicts in Turkey, whereas several countries have a developed surveillance systems...

Frequency of Hepatitis Delta Virus in Hepatitis B Surfaceantigen-positive Patients

Objectives: The prevalence of hepatitis delta virus (HDV) worldwide shows geographical differences. Although there are several studies on anti-HDV seroprevalence rates in hepatitis B surface antigen (HBsAg)-positive pati...

Acute Viral Hepatitis B with a Severe Clinical Course in Pregnancy: A Case Report

The most common cause of non-pregnancy-specific acute hepatitis during pregnancy is hepatitis B. The clinical course of viral hepatitis B in pregnancy is similar to that in non-pregnant women, and about 1% of patients ma...

Download PDF file
  • EP ID EP268764
  • DOI 10.4274/vhd.0012
  • Views 70
  • Downloads 0

How To Cite

Tayibe BAL, Yusuf ÖNLEN, Selma İLKAY ŞAHİN (2017). A Rare Side Effect of Entecavir: Hepatomegaly and Steatosis. Viral Hepatitis Journal, 23(3), 80-82. https://europub.co.uk./articles/-A-268764